GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

Taiwan · Delayed Price · Currency is TWD

34.00

+0.25 (0.74%)

Jun 18, 2026, 1:30 PM CST

-23.25% (1Y)

Market Cap	1.41B -29.1%
Revenue (ttm)	663.87M +16.6%
Net Income	15.70M
EPS	0.38
Shares Out	41.46M
PE Ratio	89.79
Forward PE	n/a
Dividend	0.70 (2.06%)
Ex-Dividend Date	n/a

Volume	22,248
Open	33.50
Previous Close	33.75
Day's Range	33.45 - 34.90
52-Week Range	33.45 - 67.10
Beta	0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About GeneFerm Biotechnology

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company provides microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as we... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1999

Employees 144

Stock Exchange Taipei Exchange

Ticker Symbol 1796

Full Company Profile

Financial Performance

Financial Statements